Sinalização Citoesquelética
Os inibidores de sinalização do citoesqueleto são compostos que interrompem as vias de sinalização que regulam o citoesqueleto, crucial para a forma celular, motilidade, divisão e transporte intracelular. Esses inibidores são usados para estudar a dinâmica das proteínas do citoesqueleto, como actina e tubulina, e seu papel em processos como migração celular, adesão e metástase do câncer. Os inibidores de sinalização do citoesqueleto são valiosos na pesquisa em biologia celular, câncer e neurobiologia. Na CymitQuimica, oferecemos uma ampla gama de inibidores de sinalização do citoesqueleto de alta qualidade para apoiar sua pesquisa nessas áreas.
Foram encontrados 1382 produtos de "Sinalização Citoesquelética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
BGB659
CAS:<p>BGB659 is effective inhibitor of RAF.</p>Fórmula:C29H29F3N4O3Pureza:98%Cor e Forma:SolidPeso molecular:538.56HR22C16
CAS:<p>HR22C16 is an effective, selective, and cell-permeable mitotic kinesin Eg5 inhibitor.</p>Fórmula:C23H23N3O3Cor e Forma:SolidPeso molecular:389.45DAT1
CAS:<p>DAT1 is an antimitotic and antiangiogenic that acts by binding to the colchicine binding site of tubulin.</p>Fórmula:C17H15N3O2SPureza:98%Cor e Forma:SolidPeso molecular:325.38Shz 1
CAS:<p>Shz 1 is a cardiogenic agent that induces phenotypic differentiation and various cardiac-specific genes including sarcomeric tropomyosin.</p>Fórmula:C13H11BrN2O3SPureza:99.57% - 99.91%Cor e Forma:SolidPeso molecular:355.21GSK-3008348
CAS:<p>GSK-3008348 is an antagonist of integrin alpha(v)beta6.</p>Fórmula:C29H37N5O2Pureza:99.547%Cor e Forma:SolidPeso molecular:487.64NSC47924
CAS:<p>NSC47924 is a laminin receptor (LR) inhibitor.</p>Fórmula:C18H17NO2Pureza:98%Cor e Forma:SolidPeso molecular:279.33ML-243
CAS:<p>inhibitor of cancer stem cells</p>Fórmula:C14H16N2OSPureza:98%Cor e Forma:SolidPeso molecular:260.35Ro 43-5054
CAS:<p>Ro 43-5054 is a small molecular, noncyclic peptidomimetic inhibitor.</p>Fórmula:C24H27N5O7Pureza:98%Cor e Forma:SolidPeso molecular:497.5D011-2120
CAS:<p>D011-2120: Antiviral that blocks microtubule growth, disrupts Golgi, and hinders viral egress.</p>Fórmula:C17H15NO3Pureza:98%Cor e Forma:SolidPeso molecular:281.31JG-48
CAS:<p>JG-48 is an inhibitor of Hsp70. JG-48 suppresses phosphorylated and total Tau in cells, endogenous Tau in neuroblastoma cells.</p>Fórmula:C20H16F3N3OS2Cor e Forma:SolidPeso molecular:435.49LDN-193665
CAS:<p>LDN-193665 is a potent inhibitor of tau kinase. It acts by targeting CDK5/p25 and GSK3β.</p>Fórmula:C15H11FN4OSPureza:98%Cor e Forma:SolidPeso molecular:314.34Diazobenzenesulfonic acid
CAS:<p>Diazobenzenesulfonic acid, white/red crystal, inhibits myosin ATPase 13 as an allosteric desensitizer.</p>Fórmula:C6H5N2O3SPureza:98%Cor e Forma:SolidPeso molecular:185.18CCT036477
CAS:<p>CCT036477 selectively inhibits Wnt/β-catenin signaling, reducing TCF/LEF transcriptional activity.</p>Fórmula:C21H18ClN3Pureza:98%Cor e Forma:SolidPeso molecular:347.84Acodazole hydrochloride
CAS:<p>Acodazole hydrochloride: synthetic imidazoquinoline with antineoplastic activity; disrupts DNA replication by intercalation.</p>Fórmula:C20H20ClN5OPureza:98%Cor e Forma:SolidPeso molecular:381.86ABH Hydrochloride
CAS:<p>ABH Hydrochloride is an arginase inhibitor, it enhances both male and female sexual arousal responses.</p>Fórmula:C6H15BClNO4Cor e Forma:SolidPeso molecular:211.45Acodazole
CAS:<p>Acodazole is a synthetic imidazoquinoline. It has antimicrobial and antineoplastic properties. It also has been shown to treat arrhythmias.</p>Fórmula:C20H19N5OPureza:98%Cor e Forma:SolidPeso molecular:345.4L 703014
CAS:<p>L 703014 is an antagonist of the fibrinogen receptor.</p>Fórmula:C24H34N4O4Pureza:98%Cor e Forma:SolidPeso molecular:442.55Tubulin inhibitor 7
CAS:<p>Tubulin inhibitor 7 is an inhibitor of tubulin and a potent inhibitor of multiple cancer cell lines (tubulin polymerization (IC50: 0.52 μM), K562 cell growth (</p>Fórmula:C21H14N2O4Pureza:98%Cor e Forma:SolidPeso molecular:358.35PF-2771
CAS:<p>PF-2771: potent CENP-E inhibitor, IC50 of 16.1 nM, used in cancer treatment.</p>Fórmula:C29H36ClN5O4Pureza:98%Cor e Forma:SolidPeso molecular:554.08Aha1/Hsp90-IN-1
CAS:<p>Aha1/Hsp90-IN-1 (Compound 17) inhibits Aha1/Hsp90, preventing tau aggregation; IC50 = 3.32 μM.</p>Fórmula:C22H17F3N4O2Cor e Forma:SolidPeso molecular:426.39OSIP-486823
CAS:<p>OSIP-486823（CP248） is a novel and potent microtubule disruptor with affinity for both protein kinase G (PKG) and microtubules.</p>Fórmula:C29H28FNO4Pureza:98.59%Cor e Forma:SolidPeso molecular:473.54NVS-PAK1-C
CAS:<p>NVS-PAK1-1: potent PAK1 inhibitor, IC50 5 nM (dephosphorylated), 6 nM (phosphorylated); ATP-competitive; weaker on PAK2 (IC50 270 nM, 720 nM).</p>Fórmula:C22H23ClF3N5OCor e Forma:SoildPeso molecular:465.9EC 144
CAS:<p>EC 144, a second-generation selective inhibitor of Hsp90 , inhibits tumor growth for Hsp90α and degradation of Her-2 in MCF-7 cells.</p>Fórmula:C21H24ClN5O2Cor e Forma:SolidPeso molecular:413.9GF 15
CAS:<p>GF 15 is a potent inhibitor of centrosomal clustering in tumor cells.</p>Fórmula:C23H21ClO6Pureza:98%Cor e Forma:SolidPeso molecular:428.86CLT-28643
CAS:<p>CLT-28643 is a specific α5β1-Integrin inhibitor that prevents fibrosis in GFS, inhibits tumor growth and angiogenesis, suppresses fibrosis and inflammation.</p>Fórmula:C19H17N3O4Pureza:99.89%Cor e Forma:SolidPeso molecular:351.36RUC-1
CAS:<p>RUC-1 is an αIIbβ3-selective ADP-induced platelet aggregation inhibitor.</p>Fórmula:C11H15N5OSPureza:98%Cor e Forma:SolidPeso molecular:265.33NSC-668036
CAS:<p>NSC-668036 is an inhibitor of Dishevelled (Dvl) protein, a key protein in wnt signaling.</p>Fórmula:C21H36N2O9Pureza:98%Cor e Forma:SolidPeso molecular:460.52S-methyl DM1
CAS:<p>S-methyl DM1 is a thiomethyl derivative of Maytansine. S-methyl DM1 binds to tubulin(Kd of 0.93 μM) and inhibts microtubule polymerization.</p>Fórmula:C36H50ClN3O10SPureza:98%Cor e Forma:SolidPeso molecular:752.31AG-205
CAS:<p>(rac)-AG-205 inhibits Pgrmc1, affects sterol gene INSIG1, and hinder NF-kB/BDNF/PI3K/AKT in neuronal hypoxic resistance.</p>Fórmula:C22H23ClN6OSCor e Forma:SolidPeso molecular:454.98ML-9 Free Base
CAS:<p>ML-9 suppresses MLCK, PKA, PKC (Ki: 4, 32, 54 μM), inhibits Akt kinase & STIM1, and induces autophagy.</p>Fórmula:C15H17ClN2O2SPureza:98%Cor e Forma:SolidPeso molecular:324.83Litronesib Racemate
CAS:<p>Litronesib is a selective, allosteric inhibitor of kinesin Eg5.Litronesib (Racemate) is the racemate of litronesib.</p>Fórmula:C23H37N5O4S2Cor e Forma:SolidPeso molecular:511.7TOK-8801
CAS:<p>TOK-8801 is a dihydroimidazole thiazole carboxamide with immunomodulatory activity.</p>Fórmula:C17H21N3OSPureza:99.97%Cor e Forma:SolidPeso molecular:315.43Creatine monohydrate
CAS:<p>Creatine monohydrate powers ATP for short, high-intensity activities in muscles and brain.</p>Fórmula:C4H11N3O3Pureza:99.87%Cor e Forma:White SolidPeso molecular:149.15Amphethinile
CAS:<p>Amphethinile is an anti-tubulin agent. The Ka of Amphethinile with tubulin is 1.3 μM.</p>Fórmula:C15H11N3SPureza:98%Cor e Forma:SolidPeso molecular:265.33CCB02
CAS:<p>CCB02 is a selective CPAP-tubulin interaction inhibitor (IC50: 689 nM) with anti-tumor activity.</p>Fórmula:C14H9N3OPureza:98.38%Cor e Forma:SolidPeso molecular:235.24Microtubule inhibitor 3
CAS:<p>Compounds 17o and 17p with furan have IC50s of 14.0 and 2.9 nM, respectively, against NCI-H460 cancer cells.</p>Fórmula:C26H23FN4O3Cor e Forma:SolidPeso molecular:458.48UR-3216
CAS:<p>UR-3216 is a prodrug, selectively antagonizing GPIIb/IIIa receptors orally, with its active form, UR-2992, binding tightly to platelets.</p>Fórmula:C27H29N7O7Pureza:98%Cor e Forma:SolidPeso molecular:563.56S516
CAS:<p>S516 is an active CKD-516 metabolite and is a potent inhibitor of tubulin polymerization(IC50 of 4.29 μM), has marked antitumor activity.</p>Fórmula:C21H19N5O4SPureza:98%Cor e Forma:SolidPeso molecular:437.47M435-1279
CAS:<p>M435-1279 is a UBE2T inhibitor. M435-1279 blocks UBE2T-mediated degradation of RACK1, leading to inhibit the hyperactivation of Wnt/β-catenin signaling pathway.</p>Fórmula:C18H17N3O5S2Pureza:97.16%Cor e Forma:SolidPeso molecular:419.47QS11
CAS:<p>QS11, a GTPase ARFGAP1, modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation.</p>Fórmula:C36H33N5O2Pureza:98.59%Cor e Forma:SolidPeso molecular:567.68FAK inhibitor 2
CAS:<p>FAK inhibitor 2, antitumor and anti-angiogenesis activitiesis ,is a potent focal adhesion kinase (FAK) inhibitor with an IC50 of 0.07 nM .</p>Fórmula:C29H33F3N8O2S2Cor e Forma:SolidPeso molecular:646.75β-catenin-IN-3
CAS:<p>β-catenin-IN-3 is a selective and potent β-catenin inhibitor (KD: 54.96 nM) that targets a cryptic regulatory site of β-catenin and significantly reduces the</p>Fórmula:C19H20Br2N2OSCor e Forma:SolidPeso molecular:484.252-Fluoropalmitic acid
CAS:<p>2-Fluoropalmitic acid, glioblastoma (GBM) by inhibiting the viability, proliferation, suppressing the expression of phosphorylated erk, CD133, and SOX-2, MMP-2.</p>Fórmula:C16H31FO2Cor e Forma:SolidPeso molecular:274.41Retaspimycin Hydrochloride
CAS:<p>Retaspimycin Hydrochloride is a potent and water-soluble Hsp90 inhibitor(Hsp90 and Grp9 with EC50s of 119 nM).</p>Fórmula:C31H46ClN3O8Pureza:98%Cor e Forma:SolidPeso molecular:624.17Anticancer agent 48
CAS:<p>Compound 48: broad-spectrum, anti-proliferative, inhibits microtubules, active in vivo, with potential for tumor research.</p>Fórmula:C26H25N3O4Cor e Forma:SolidPeso molecular:443.49MPC-3100
CAS:<p>MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of Hsp90 with significant antitumor activity [1].</p>Fórmula:C22H25BrN6O4SCor e Forma:SolidPeso molecular:549.44Akt1 and Akt2-IN-1
CAS:<p>Akt1 and Akt2-IN-1 is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM). It has potent and balanced activity.</p>Fórmula:C33H29N7OCor e Forma:SolidPeso molecular:539.63Tubulin polymerization-IN-39
<p>Tubulin-IN-39 inhibits polymerization (IC50: 4.9 μM), blocks colchicine site, stops cancer growth.</p>Fórmula:C21H21N5O5Cor e Forma:SolidPeso molecular:423.42Integrin-IN-2
CAS:<p>Integrin-IN-2, an oral αv integrin blocker, enhances αvβ6/3/5/8 affinities with pIC50s: 7.8/8.4/8.4/7.4.</p>Fórmula:C27H30N4O3Pureza:98%Cor e Forma:SolidPeso molecular:458.55Drp1-IN-1
CAS:<p>Drp1-IN-1 (comp A-7) is a Drp1 protein inhibitor (IC50: 0.91 μM).</p>Fórmula:C22H24N8OSCor e Forma:SolidPeso molecular:448.54Microtubule inhibitor 1
CAS:<p>Microtubule inhibitor 1 is an antitumor agent with microtubule polymerization inhibitory activity(IC50 = 9-16 nM, in cancer cells).</p>Fórmula:C21H19NO3Pureza:98%Cor e Forma:SolidPeso molecular:333.38Tubulin inhibitor 28
CAS:<p>Compound 2g, a tubulin inhibitor with an IC50 of 1.2 μM, inhibits MCF-7 cell proliferation.</p>Fórmula:C12H8Br2S2Cor e Forma:SolidPeso molecular:376.13ARUK3001185
CAS:<p>ARUK3001185 (8l): potent, selective Notum inhibitor; oral, brain-penetrant; IC50=6.7 nM; for rodent disease models.</p>Fórmula:C9H4Cl2F3N3Cor e Forma:SolidPeso molecular:282.05CHPG sodium salt
CAS:<p>CHPG sodium salt is a selective agonist of mGluR5 and activates the ERK and Akt signaling pathways.</p>Fórmula:C8H7ClNNaO3Pureza:>99.99%Cor e Forma:SolidPeso molecular:223.59Valategrast
CAS:<p>Valategrast: potent, oral dual α4β1/α4β7 integrin antagonist, may treat COPD and asthma.</p>Fórmula:C30H32Cl3N3O4Pureza:98%Cor e Forma:SolidPeso molecular:604.95Cardionogen 1
CAS:<p>Wnt signaling modulator</p>Fórmula:C13H14N4OSPureza:98%Cor e Forma:SolidPeso molecular:274.34EMD534085
CAS:<p>EMD534085 is an effective and selective mitotic kinesin-5 inhibitor (IC50: 8 nM).</p>Fórmula:C25H31F3N4O2Pureza:98%Cor e Forma:SolidPeso molecular:476.53Wnt/β-catenin agonist 1
CAS:<p>Wnt/β-catenin agonist 1 is an agonist of Wnt/β-catenin signalling pathway(EC50 of 0.27 μM).</p>Fórmula:C22H25N3O2Pureza:98%Cor e Forma:SolidPeso molecular:363.45BCR-ABL-IN-2
CAS:<p>BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).</p>Fórmula:C24H25Cl2N5O3Pureza:98%Cor e Forma:SolidPeso molecular:502.39Bimoclomol
CAS:<p>Bimoclomol is a heat shock protein co-inducer used for the research of cardiovascular diseases.</p>Fórmula:C14H20ClN3O2Cor e Forma:SolidPeso molecular:297.78UR-1505
CAS:<p>UR-1505 is an NF-AT inhibitor that prevents T cell activation without reducing cell viability.</p>Fórmula:C10H7F5O4Pureza:98%Cor e Forma:SolidPeso molecular:286.15c-ABL-IN-2
CAS:<p>C-ABL-IN-2 is a potent c-Abl protein inhibitor, promising for research in cancer and neurodegenerative diseases like ALS and PD.</p>Fórmula:C21H20N4OCor e Forma:SolidPeso molecular:344.41AKT-IN-7
CAS:<p>AKT-IN-7 (compound 1-P1) is a potent inhibitor of AKT. AKT-IN-7 has potential for cancer research.</p>Fórmula:C23H27ClN6O2Cor e Forma:SolidPeso molecular:454.95YW1128
CAS:<p>YW1128 inhibits Wnt/β-catenin signaling (IC50=4.1 nM), reduces β-catenin, affects gene expression, and improves glucose tolerance and weight control in mice.</p>Fórmula:C20H17N5OCor e Forma:SolidPeso molecular:343.38MT-7
CAS:<p>MT-7 is a tubulin polymerization inhibitor.</p>Fórmula:C22H17N3O2Pureza:98%Cor e Forma:SolidPeso molecular:355.39Kif15-IN-1
CAS:<p>Kif15-IN-1 is a Kif15 inhibitor with antiproliferative and potential anticancer activity, which can be used to study gastric cancer.</p>Fórmula:C20H22N4O5SPureza:99.39% - 99.39%Cor e Forma:SolidPeso molecular:430.48Anticancer agent 49
CAS:<p>Anticancer agent 49, also 69, hinders cell growth and microtubule aggregation, with potential in solid and blood cancer research.</p>Fórmula:C26H25N3O4Cor e Forma:SolidPeso molecular:443.49Tubulin polymerization-IN-19
CAS:<p>Tubulin aggregation-IN-19 (compound 4) is a potent tubulin aggregation inhibitor that has shown potential in breast cancer and drug-resistant colon cancer.</p>Fórmula:C25H25NO5Cor e Forma:SolidPeso molecular:419.47HSP90-IN-12
CAS:<p>VAC, a potent anti-cancer vibsanin A analog, inhibits cell proliferation and affects HSP90 protein levels.</p>Fórmula:C25H36O4Cor e Forma:SolidPeso molecular:400.55DJ101
CAS:<p>DJ101: A stable tubulin inhibitor that bypasses multidrug resistance efflux pumps.</p>Fórmula:C23H20N4O3Pureza:98%Cor e Forma:SolidPeso molecular:400.43Hsp90-IN-15
CAS:<p>Hsp90-IN-15: Hsp90 blocker with anticancer properties; halts S phase, triggers apoptosis, cuts Hsp90 in Hela cells.</p>Fórmula:C23H27F3N4Cor e Forma:SolidPeso molecular:416.48YM-01 Tosylate
CAS:<p>YM-01 Tosylate, a potent antitumor agent, selectively targets cancer cells and overcoming tamoxifen resistance.</p>Fórmula:C27H27N3O4S3Cor e Forma:SolidPeso molecular:553.72Displurigen
CAS:<p>Displurigen is an inhibitor of ATPase activity of HSP70.</p>Fórmula:C15H10O4SPureza:98%Cor e Forma:SolidPeso molecular:286.3AKT-IN-9
CAS:<p>AKT-IN-9, a potent AKT inhibitor, may aid breast/prostate cancer studies. See WO2021185238A1.</p>Fórmula:C24H29ClN6OCor e Forma:SolidPeso molecular:452.98ZW4864 free base
CAS:<p>ZW4864 (free base) is an orally active and selective β catenin/B-Cell lymphoma 9 protein protein interaction ( β catenin/BCL9 PPI ) inhibitor.</p>Fórmula:C33H42N6O3Pureza:99.81%Cor e Forma:SolidPeso molecular:570.72Box5
CAS:<p>Box5 blocks Wnt5a, reducing Ca2+ release and cell migration; promising for melanoma studies.</p>Fórmula:C30H50N6O13S2Cor e Forma:SolidPeso molecular:766.88Malonganenone A
CAS:<p>Malonganenone A is a selective plasmodial Hsp70s modulator. It also has antimalarial activity.</p>Fórmula:C26H38N4O2Cor e Forma:SolidPeso molecular:438.61Mivobulin
CAS:<p>Mivobulin is an inhibitor of tubulin .</p>Fórmula:C17H19N5O2Pureza:98%Cor e Forma:SolidPeso molecular:325.37NC043
CAS:<p>NC043 is an inhibitor of Wnt/β-catenin signaling, it forms a covalent bond with the Cys-516 residue of CARF.</p>Fórmula:C20H26O4Pureza:98%Cor e Forma:SolidPeso molecular:330.42KIF18A-IN-3
CAS:<p>KIF18A-IN-3 is a KIF18A inhibitor (IC50=61 nM) that causes significant mitotic arrest and increases the number of mitotic cells in tumor tissues.</p>Fórmula:C28H38N4O5S2Pureza:98.45%Cor e Forma:SolidPeso molecular:574.76Zaurategrast ethyl ester
CAS:<p>Zaurategrast ethyl ester, an α4β1/α4β7 integrin antagonist prodrug of CT7758, treats inflammatory/autoimmune conditions.</p>Fórmula:C28H29BrN4O3Pureza:98%Cor e Forma:SolidPeso molecular:549.46IMB-10
CAS:<p>IMB-10 is an alphaMbeta2 integrin modulator, inhibiting leukocyte migration and recruitment in vitro and in vivo.</p>Fórmula:C19H15NOS2Cor e Forma:SolidPeso molecular:337.46(R)-Filanesib
CAS:<p>(R)-Filanesib is the R-enantiomer of ARRY-520. (R)-Filanesib is a synthetic kinesin spindle protein (KSP) inhibitor (IC50: 6 nM).</p>Fórmula:C20H22F2N4O2SCor e Forma:SolidPeso molecular:420.48CH5138303
CAS:<p>CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.</p>Fórmula:C19H18ClN5O2SPureza:98%Cor e Forma:SolidPeso molecular:415.9Tau protein aggregation-IN-1
CAS:<p>Tau Protein Aggregation-IN-1 (Compound 0c) serves as an inhibitor of Tau protein aggregation, applicable in research related to protein folding disorders</p>Fórmula:C17H11BrN2O2Cor e Forma:SolidPeso molecular:355.19CK2-IN-9
CAS:<p>CK2-IN-9, a potent and selective CK2 kinase inhibitor, exhibits an inhibitory concentration (IC50) of 3 nM against its target enzyme and hampers Wnt reporter</p>Fórmula:C23H29N9OCor e Forma:SolidPeso molecular:447.54Zaurategrast ethyl ester sulfate
CAS:<p>Zaurategrast ethyl ester sulfate is a α4β1/α4β7 integrin antagonist, and used for the treatment of inflammatory and autoimmune disorders.</p>Fórmula:C56H60Br2N8O10SPureza:98%Cor e Forma:SolidPeso molecular:1197.01Tubulin polymerization-IN-27
CAS:<p>Compound 5j inhibits tubulin polymerization, arrests cell cycle at G2/M phase, and induces apoptosis.</p>Fórmula:C22H20N2O2Cor e Forma:SolidPeso molecular:344.41CK548
CAS:<p>CK548 is a novel actin-related protein (Arp)2/3 complex inhibitor.</p>Fórmula:C15H11BrClNO2SPureza:98%Cor e Forma:SolidPeso molecular:384.68SC-10
CAS:<p>SC-10 is a direct activator of PKC with potential antiproliferative activity, useful in leukemia research.</p>Fórmula:C17H22ClNO2SPureza:99.24% - 99.58%Cor e Forma:SolidPeso molecular:339.88MG-2119
CAS:<p>MG-2119 is a potent inhibitor of monomeric tau and α-syn aggregation and can be used to study neurological diseases.</p>Fórmula:C27H29N5O4Cor e Forma:SolidPeso molecular:487.55AN-019
CAS:<p>AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.</p>Fórmula:C25H17F6N5OPureza:98.99%Cor e Forma:SolidPeso molecular:517.43isoCA-4
CAS:<p>isoCA-4 is a Combretastatin A4 derivative. isoCA-4 is a tubulin polymerization inhibitor with anti-proliferative activities [1].</p>Fórmula:C18H20O5Cor e Forma:SolidPeso molecular:316.35Tubulin polymerization-IN-29
CAS:<p>Tubulin polymerization-IN-29 inhibits microtubule assembly, has anti-proliferative properties, and arrests HeLa cells at G2/M.</p>Fórmula:C25H20FNO6Cor e Forma:SolidPeso molecular:449.43BNC105P
CAS:<p>BNC105P, a prodrug VDA, converts to BNC105, blocks tubulin polymerization, disrupts tumor vessels, and evades P-glycoprotein resistance.</p>Fórmula:C20H21O10PCor e Forma:SolidPeso molecular:452.34856BrCaQ
CAS:<p>6BrCaQ inhibits TRAP1, has antiproliferative effects, and is used in 6BrCaQ-TPP synthesis.</p>Fórmula:C18H15BrN2O3Cor e Forma:SolidPeso molecular:387.23Ellipticine quinone
CAS:<p>Ellipticine quinone (NSC-383230) outperforms mdivi-1 in inhibiting Drp1, reduces lung cancer growth, and lessens IR injury by curbing mitochondrial issues.</p>Fórmula:C15H8N2O2Cor e Forma:SolidPeso molecular:248.24Dynamin IN-1
CAS:<p>Dynamin IN-1 is a potent dynamin inhibitor with an IC 50 value of 1.0 µM .</p>Fórmula:C23H24N2OCor e Forma:SolidPeso molecular:344.45PU3
CAS:<p>PU3 is an inhibitor of Hsp90.</p>Fórmula:C19H25N5O3Pureza:98%Cor e Forma:SolidPeso molecular:371.43Conteltinib
CAS:<p>Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK and Pyk2. It can be used to study lymphoma.</p>Fórmula:C32H45N9O3SPureza:98.12% - 99.54%Cor e Forma:SolidPeso molecular:635.82
